2018 was the biggest year to date in health tech funding. Not only were deal sizes and number of deals off the charts, but the average time between funding stages has shortened, making way for more later stage deals. Hear insights and strategies from companies that have exited or are seeing Series C and beyond.
This session requires additional registration. Learn more here.